Skip to content
AnalystLens

PROCTER & GAMBLE Co 8-K Report (Dec 3, 1997)

Reports
Other Events
Filing Date
Filed December 3, 1997
Period End
December 3, 1997
Security
PG
In the record · 2016–202610-K1210-Q328-K226

PG filed 12 annual reports (10-K), 32 quarterly reports (10-Q) and 226 current reports (8-K) between 2016 and 2026.

  1. FY2019 annual report10-K · Aug ’19Aug ’19
  2. Leadership change8-K · Jan ’22Jan ’22
  3. Leadership change8-K · Dec ’25Dec ’25

Summary

Summary of the 8-K filed December 3, 1997. Cited figures are marked; the original filing is the authoritative source.

The Procter & Gamble Company filed this Form 8-K on December 3, 1997, to report a small, routine sale of unregistered equity securities under Item 9 (Regulation S).

On November 25, 1997, P&G sold 6,423 shares of its common stock to employees of its subsidiaries for approximately $496,626,a relying on the Regulation S exemption from registration for offshore transactions. No underwriter or placement agent was used. From an investor standpoint, this filing is immaterial.

The proceeds of roughly $0.5 millionb are negligible relative to P&G's size as one of the world's largest consumer products companies, and the transaction does not meaningfully dilute existing shareholders. The implied price of about $77 per share is consistent with the range at which P&G traded in late 1997, though the filing itself does not state a per-share price. The disclosure is best understood as a compliance filing.

Companies must report certain unregistered sales of equity, and employee stock purchase arrangements conducted through foreign subsidiaries commonly fall under Regulation S. The filing provides no information on earnings, guidance, strategy, or operations, so investors should look to P&G's annual and quarterly reports for material developments.

Key Highlights

  1. Filing type: Form 8-K, Item 9, reporting a sale of unregistered equity securities under Regulation S
  2. Transaction date: November 25, 1997, with the 8-K filed December 3, 1997
  3. Shares sold: 6,423 shares of P&G common stock to employees of P&G subsidiaries
  4. Aggregate proceeds: approximately $496,626, an immaterial amount for P&G
  5. Implied price: roughly $77 per share, calculated from the disclosed figures and not stated in the filing
  6. No underwriter or placement agent was used, so the sale was made directly by the company
  7. Exemption relied upon: Regulation S, which covers offshore offerings to non-U.S. persons, consistent with sales to employees of foreign subsidiaries

Frequently Asked Questions

  1. Does this 8-K filing indicate any material change in P&G's financial condition?

    No. The filing reports a sale of about 6,423 shares for roughly $496,626. That amount is immaterial for a company of P&G's scale and does not signal any change in financial condition, operations, or outlook.

  2. Does this sale dilute existing P&G shareholders?

    Only negligibly. The 6,423 shares are a very small fraction of P&G's outstanding common stock, so the dilutive effect on existing shareholders is effectively zero.

  3. Why did P&G sell shares to employees under Regulation S?

    Regulation S provides a safe harbor from U.S. registration requirements for offers and sales made outside the United States to non-U.S. persons. Because the buyers were employees of P&G's foreign subsidiaries, the company relied on this exemption. Such sales are typically tied to employee stock or savings plans.

  4. Was there an underwriter involved in this transaction?

    No. The filing states that no underwriter or placement agent was used, meaning P&G sold the shares directly to the employees without intermediaries and without a public offering.

  5. Should investors take any action based on this filing?

    No. This is a routine compliance disclosure with no bearing on investment decisions. Investors should instead review P&G's 10-K, 10-Q, and earnings releases for information on performance, strategy, and financial position.